{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T22:42:35Z","timestamp":1789512155253,"version":"build-2803163510"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.1097\/mao.0b013e318248ee1f","type":"journal-article","created":{"date-parts":[[2012,2,11]],"date-time":"2012-02-11T02:31:39Z","timestamp":1328927499000},"page":"629-633","source":"Crossref","is-referenced-by-count":34,"title":["Magnetic Resonance Imaging Fails to Show Evidence of Reduced Endolymphatic Hydrops in Gentamicin Treatment of M\u00e9ni\u00e8re\u2019s Disease"],"prefix":"10.1097","volume":"33","author":[{"given":"Francesco","family":"Fiorino","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca B.","family":"Pizzini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franco","family":"Barbieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Beltramello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-24-20210212","first-page":"257","article-title":"Intratympanic gentamicin titration therapy for intractable Menieres disease.","volume":"20","author":"Atlas","year":"1999","journal-title":"Am J Otol"},{"key":"R2-24-20210212","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1097\/00005537-200401000-00018","article-title":"Long-term results after interval therapy with intratympanic gentamicin for Menieres disease.","volume":"114","author":"Lange","year":"2004","journal-title":"Laryngoscope"},{"key":"R3-24-20210212","first-page":"35","article-title":"Low-dose intratympanic treatment for dizziness in Menieres disease.","volume":"29","author":"Longridge","year":"2000","journal-title":"J Otolaryngol"},{"key":"R4-24-20210212","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1080\/000164801300102879","article-title":"Intratympanic therapy for Menieres disease: effect of administration of low concentration of gentamicin.","volume":"121","author":"Quaranta","year":"2001","journal-title":"Acta Otolaryngol"},{"key":"R5-24-20210212","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1080\/00016480410016621","article-title":"Selective vestibular ablation by intratympanic gentamicin in patients with unilateral active Menieres disease: a prospective, double blind, placebo-controlled, randomized clinical trial.","volume":"124","author":"Stokroos","year":"2004","journal-title":"Acta Otolaryngol"},{"key":"R6-24-20210212","first-page":"435","article-title":"Intratympanic gentamicin injection for the treatment of the Menieres disease.","volume":"19","author":"Youssef","year":"1998","journal-title":"Am J Otol"},{"key":"R7-24-20210212","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1097\/01.mlg.0000149439.43478.24","article-title":"Intratympanic gentamicin for Menieres disease: a meta-analysis.","volume":"114","author":"Cohen-Kerem","year":"2004","journal-title":"Laryngoscope"},{"key":"R8-24-20210212","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.1097\/MLG.0b013e3181453a3c","article-title":"Treatment of Menieres disease by low-dosage intratympanic gentamicin application: effect on otolith function.","volume":"117","author":"Helling","year":"2007","journal-title":"Laryngoscope"},{"key":"R9-24-20210212","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1097\/MAO.0b013e31820e6dc8","article-title":"Treatment of Menieres disease with on-demand intratympanic gentamicin injections.","volume":"32","author":"Manrique-Huarte","year":"2011","journal-title":"Otol Neurotol"},{"key":"R11-24-20210212","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1097\/00129492-200407000-00023","article-title":"Intratympanic gentamicin therapy for Menieres disease: a meta-analysis.","volume":"25","author":"Chia","year":"2004","journal-title":"Otol Neurotol"},{"key":"R12-24-20210212","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/00034894800896S302","article-title":"Aminoglycoside ototoxicity following middle ear injection.","volume":"89","author":"Rudnick","year":"1980","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"R13-24-20210212","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/BF00463571","article-title":"Gentamicin and other ototoxic antibiotics for the transtympanic treatment for Menieres disease.","volume":"246","author":"Lange","year":"1989","journal-title":"Arch Otorhinolaryngol"},{"key":"R14-24-20210212","first-page":"1155","article-title":"Ototoxicity of gentamicin. Histopathologic and functional results in the cat.","volume":"74","author":"Webster","year":"1970","journal-title":"Trans Am Acad Opthalmol Otolaryngol"},{"key":"R15-24-20210212","first-page":"340","article-title":"Intratympanic gentamicin therapy for Menieres disease: preliminary comparison of two regimens.","volume":"24","author":"Toth","year":"1995","journal-title":"J Otolaryngol"},{"key":"R16-24-20210212","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.amjoto.2010.07.021","article-title":"Single-shot, low-dose intratympanic gentamicin in Meniere disease: role of vestibular-evoked myogenic potentials and caloric test in the prediction of outcome.","volume":"32","author":"Gode","year":"2011","journal-title":"Am J Otolaryngol"},{"key":"R17-24-20210212","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1097\/MLG.0b013e31817d01cd","article-title":"Dependence of hearing changes on the dose of intratympanically applied gentamicin: a meta-analysis using mathematical simulations of clinical drug delivery protocols.","volume":"118","author":"Salt","year":"2008","journal-title":"Laryngoscope"},{"key":"R18-24-20210212","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/S0196-0709(85)80013-2","article-title":"Gentamicin tympanoclisis: effects on the vestibulary secretory cells.","volume":"6","author":"Pender","year":"1985","journal-title":"Am J Otolaryngol"},{"key":"R19-24-20210212","doi-asserted-by":"crossref","first-page":"404","DOI":"10.3109\/00016488909125546","article-title":"Dynamic changes following combined treatment with gentamicin and ethacrynic acid with and without acoustic stimulation. Cellular uptake and functional correlates.","volume":"108","author":"Hayashida","year":"1989","journal-title":"Acta Otolaryngol"},{"key":"R20-24-20210212","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/BF00454037","article-title":"Pattern of gentamicin-induced cochlear degeneration in the guinea pig. A morphological and electrophysiological study.","volume":"236","author":"Tange","year":"1982","journal-title":"Arch Otorhinolaryngol"},{"key":"R21-24-20210212","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0196-0709(82)80042-2","article-title":"Vestibular ototoxicity in the chick: effects of streptomycin on equilibrium and on ampullary dark cells.","volume":"6","author":"Park","year":"1982","journal-title":"Am J Otolaryngol"},{"key":"R22-24-20210212","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1097\/MLG.0b013e31802c300c","article-title":"Visualization of endolymphatic hydrops in patients with Menieres disease.","volume":"17","author":"Nakashima","year":"2007","journal-title":"Laryngoscope"},{"key":"R23-24-20210212","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s00405-010-1353-5","article-title":"MRI performed after intratympanic gadolinium administration in patients with Menieres disease. Correlation with symptoms and signs.","volume":"268","author":"Fiorino","year":"2011","journal-title":"Eur Arch Otolaryngol"},{"key":"R24-24-20210212","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1097\/MAO.0b013e31820e7614","article-title":"Reliability of MRI performed after intratympanic administration of gadolinium in the identification of endolymphatic hydrops in patients with Menieres disease.","volume":"32","author":"Fiorino","year":"2011","journal-title":"Otol Neurotol"},{"key":"R25-24-20210212","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1097\/MAO.0b013e31822a1ce2","article-title":"Progression of endolymphatic hydrops in Menieres disease as evaluated by magnetic resonance imaging.","volume":"32","author":"Fiorino","year":"2011","journal-title":"Otol Neurotol"},{"key":"R27-24-20210212","doi-asserted-by":"crossref","first-page":"36","DOI":"10.2302\/kjm.35.36","article-title":"Intratympanic application of gentamicin for treatment of Menieres disease.","volume":"35","author":"Beck","year":"1986","journal-title":"Keio J Med"},{"key":"R28-24-20210212","first-page":"534","article-title":"Electrocochleography and gentamicin therapy for Menieres disease: a preliminary report.","volume":"21","author":"Adamonis","year":"2000","journal-title":"Am J Otol"},{"key":"R29-24-20210212","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1212\/WNL.59.9.1442","article-title":"Intratympanic gentamicin injections for Menieres disease.","volume":"59","author":"de Waele","year":"2002","journal-title":"Neurology"},{"key":"R30-24-20210212","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1126\/science.7839150","article-title":"Mammalian vestibular hair cell regeneration.","volume":"267","author":"Rubel","year":"1995","journal-title":"Science"},{"key":"R31-24-20210212","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.anl.2009.04.013","article-title":"Changes in endolymphatic hydrops in a patient with Menieres disease observed using magnetic resonance imaging.","volume":"37","author":"Sone","year":"2010","journal-title":"Auris Nasus Larynx"},{"key":"R32-24-20210212","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.3109\/00016480802593513","article-title":"Endolymphatic hydrops and therapeutic effects are visualized in `atypical Menieres disease.","volume":"129","author":"Miyagawa","year":"2009","journal-title":"Acta Otolaryngol"}],"container-title":["Otology &amp; Neurotology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MAO.0b013e318248ee1f","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T20:38:02Z","timestamp":1786048682000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00129492-201206000-00024"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6]]},"references-count":30,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/mao.0b013e318248ee1f","relation":{},"ISSN":["1531-7129"],"issn-type":[{"value":"1531-7129","type":"print"}],"subject":[],"published":{"date-parts":[[2012,6]]}}}